Biopsy specimens were fixed in formol saline, decalcified in Gooding's and Stuart's solution for eight hours, and paraffin wax embedded sections were stained by Foot's silver reticulin method. Reticulin was assessed independently by two observers and graded as not increased (0), slightly increased (+), moderately increased (+ +), or greatly increased (+ + +). Assessment was made with no knowledge of the patient's identity or other details and differed between the two observers in 24 of the 63 cases by a single grade. In these cases the trephine biopsy specimen was re-examined jointly and agreement reached.
Immunophenotyping was performed by standard indirect immunofluorescence labelling of bone marrow mononuclear cell suspensions. CD1O (CALLA), CD19 (B4), CD20 (B1), and CD2 (T1 1) were routinely assessed in most patients. CD1 (T6), CD4 (T4), CD8 (T8), CD7 (Leu 9), CD13 (MY 7), CD14 (MY 4), CD33 (MY 9), surface membrane immunoglobulin, and glycoprotein Ilb/IlIa were also tested in several patients. Terminal deoxynucleotidyl transferase (Tdt) was assessed by indirect immunofluorescence using a polyclonal rabbit anti-Tdt antibody on a fresh marrow slide or marrow cytospin in all cases. Cytoplasmic p has only been tested for more recently and results are not included in the analyses. Immunophenotypes were defined as follows: 1 Common ALL (CALL): Tdt positive, CDIO positive, T cell markers negative (in all but four cases > 30% of blasts were CDl9 or CD20 positive). 2 TcellALL (T-ALL): CD2, CD1, or CD7 positive, CD19 and CD20 negative. Tdt positive or negative. 3 Other ALL: (table) . Details of the peripheral blood count were taken from the presenting blood sample. Splenomegaly and lymphadenopathy were as recorded at initial presentation.
Cytogenetic analyses were performed on unstimulated bone marrow cultures and metaphase cells stained by standard G-banding techniques.
Statistical analysis was performed using Fisher's exact probability test.
Results
Sixty three trephine biopsy specimens were studied. The table shows the assessment of reticulin according to immunophenotype.
The groups were divided into T-ALL, and those with B lineage markers (CALL and others), and into no fibrosis (0) and fibrosis (+, + +, + + +) for statistical analysis. The association between leukaemia with B lineage markers and presence of fibrosis was significant (2p < 0-005). There was no trend or significant difference in presenting haemoglobin (mean 7 g/dl), mean corpuscular volume (mean 83fl), or platelet count when analysed according to immunophenotype or degree of fibrosis. White cell count was higher for the group without fibrosis but this trend disappeared when analysed for CALL alone. Splenomegaly (35 of 63) showed no significant association with fibrosis, though when analysed for CALL alone, splenomegaly was less common in those without fibrosis (one of eight) than in those with fibrosis (23 of 39). This difference was just significant (2p < 0 05).
Chromosomes were successfully studied in 44 of 63 cases. No association between particular abnormalities or groups of abnormalities with degree of fibrosis could be discerned. Seven of the 63 children have relapsed since the presenting marrow biopsy was obtained (median relapse free follow up 21 months) and three children died during or failed induction. These show no significant association with degree of fibrosis. Of 24 cases with moderate or pronounced increase in reticulin staining 17 had repeat trephine biopsies performed 30 days after starting treatment and, in all but two, reticulin had returned to normal. The principal finding of our study was the strong association between the expression of B lineage markers and presence of marrow fibrosis. More careful inspection of the immunophenotypes shows that three cases with marrow fibrosis showed expression of T cell markers. One with a moderate and one with a pronounced increase in reticulin both showed coexpression of T and B cell markers including CDIO and were classified as "other". One with a slight increase in reticulin, expressing Tdt 95%, CD10 40%, CDI 92%, CD7 40%, CD2 5%, CD19 and CD20 <1% was classified as T-ALL. No other case of T-ALL expressed CD10. One case of null cell leukaemia with t(4:11) and a slight increase in reticulin later relapsed expressing CD19. All other cases with fibrosis were CALL or expressed only B cell markers at diagnosis. There was no association between "maturity" of B cell markers and degree of fibrosis in either the CALL or "other" groups. The proportion of T-ALL among the total was similar to that previously found in the Northern region3 and elsewhere in the United Kingdom. 4 Apart from a weak association between splenomegaly and fibrosis in CALL, no independent correlation was found between degree of fibrosis and other presenting features. In particular, the association between absence of fibrosis and high presenting white cell count seemed to reflect the distribution ofT-ALL.
Improvements in the treatment of childhood ALL have resulted in fewer relapses such that considerably longer follow up of larger series of patients is required before any association between prognosis and fibrosis might be determined. Despite the small size of this group, there does seem to be a biological difference in the ability of distinct immunologically defined subgroups of ALL to stimulate a fibrotic reaction in the marrow.
